Clinical trial
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
NCT07156578
Study timeline
Study start (actual)2025-11-10Date precision: day
Registry last updated2026-02-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypothalamic Obesityunresolved
Interventions
BivamelagonDRUG
Sponsors & collaborators
Rhythm Pharmaceuticals, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07156578 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.